Table 1.
Case No. | Race | Clinical Features
|
8q24 SNP genotypes
|
MYC CN | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Age | Gleason Score | Stage | rs7008482 G/T | rs16901979 A/C | rs6983267 G/T | rs7014346 A/G | rs1447295 A/C | |||
21 | EA | 63 | 9 | T3BN0MX | ■ | C | T | G | ■ | 3.93 |
18 | EA | 55 | 7 | T2N0MX | C | G | A | ■ | 3.47 | |
12 | AA | 59 | 7 | T3BN0MX | G | A | G | ■ | ■ | 2.81 |
16 | EA | 70 | 7 | T3AN0MX | T | C | ■ | G | C | 2.48 |
13 | AA | 61 | 7 | T3AN0MX | G | C | □ | G | C | 2.46 |
5 | AA | 55 | 6 | T2N0MX | G | C | ■ | G | □ | 2.43 |
9 | AA | 65 | 9 | T3AN0MX | G | A | G | G | C | 2.24 |
1 | AA | 62 | 6 | T2N0MX | G | G | A | 2.2 | ||
6 | AA | 51 | 6 | T3BN0MX | G | G | G | 2.2 | ||
3 | AA | 58 | 6 | T3AN0MX | G | □ | G | G | A | 2.18 |
24 | EA | 59 | 6 | T3AN0MX | □ | C | T | G | C | 2.11 |
26 | EA | 55 | 6 | T2N0MX | T | C | □ | □ | □ | 2.09 |
20 | EA | 61 | 6 | T2N0MX | □ | □ | □ | □ | C | 2.07 |
19 | EA | 55 | 6 | T2N0MX | □ | C | G | A | □ | 2.05 |
25 | EA | 65 | 7 | T3AN0MX | G | C | □ | □ | C | 2.04 |
15 | AA | 61 | 7 | T3AN0MX | □ | A | G | □ | □ | 1.93 |
17 | EA | 57 | 6 | T2N0MX | T | C | T | G | C | 1.92 |
14 | AA | 59 | 7 | T3AN0MX | G | C | G | A | C | 1.91 |
23 | EA | 43 | 6 | T2N0MX | □ | C | T | G | C | 1.91 |
27 | EA | 55 | 7 | T3BN0MX | G | C | G | □ | C | 1.89 |
22 | EA | 68 | 6 | T3AN0MX | □ | C | T | G | □ | 1.84 |
10 | AA | 59 | 7 | T3AN0MX | □ | C | □ | □ | C | 1.82 |
2 | AA | 56 | 6 | T2N0MX | G | □ | G | □ | □ | 1.77 |
11 | AA | 46 | 7 | T3AN0MX | □ | □ | G | □ | C | 1.76 |
8 | AA | 66 | 7 | T3AN0MX | G | A | G | □ | □ | 1.68 |
7 | AA | 48 | 7 | T3AN1MX | G | A | G | □ | □ | 1.63 |
4 | AA | 57 | 7 | TXN0MX | G | G | G | □ | 1.34 |
□ Heterozygous without AI. ■ Heterozygous with high AI. Heterozygous with moderate AI.